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ABSTRACT
Background: Basal cell carcinomas (BCCs)
usually occur in sun-exposed areas. However,
they may also occur—albeit infrequently—in
unusual locations, such as the nipple-areola
complex.
Methods: Using the PubMed database, an
extensive literature search was performed for
the following keywords: areola, basal cell
carcinoma, and nipple. Papers and references
cited in those papers were reviewed to
accumulate reports of patients with BCC of
the areola and nipple.
Results: BCC of the areola and nipple has been
described in 55 individuals: 35 males and 20
females. The onset age ranged from 35 to
86 years. The median onset age in males was
61 years, whereas the median onset age in
females was 66 years. BCC of the NAC
predominantly occurred in Caucasians
(75.7%). BCC of the nipple-areola complex
(NAC) was observed on the left (54.9%) more
frequently than the right (45.1%). Clinical
presentation was variable and commonly
included scaly or ulcerated plaques and
nodules. This tumor was typically associated
with the nodular (42.9%) or superficial (30.9%)
subtype of BCC. The most common treatment
was excision. There were three reported patients
who had metastatic disease to their lymph
nodes; one of the patients died from his tumor.
Conclusion: The nipple and areola are
uncommon sites of BCC. BCC of the
nipple-areola complex is less frequently observed
in females (36.4%), as this is more commonly a
photo-protected site. BCC of the NAC has been
considered to behave more aggressively than
BCCs at other anatomical sites; however, the
BCCs are frequently associated with a
non-aggressive histologic subtype. Treatment
usually involves complete excision of the BCC.
Tumor recurrence was uncommon following
successful treatment of the primary neoplasm.
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INTRODUCTION
Basal cell carcinoma (BCC) is the most common
cutaneous malignancy and accounts for
approximately 80 percent of all nonmelanoma
skin cancers [1]. Exposure to ultraviolet
radiation is the main environmental risk factor
associated with the development of BCCs,
although they have also been found to occur
less frequently in photo-protected sites. Albeit
rare, BCCs of the nipple-areola complex (NAC)
have been suggested as being more aggressive
with higher rates of metastasis to regional
lymph nodes [2]. To date, three cases of BCC
of the NAC metastatic to the lymph nodes have
been described. In comparison, metastatic BCCs
from all anatomic sites have been described in a
total of 364 cases from 1894 through 2011 [3].
As a result, there has been controversy over the
management of BCCs of the NAC.
To address the surveillance and management
of BCC of the NAC, an extensive world
literature review was conducted to identify
cases reported between 1893 and 2016. We
review the characteristics of individuals who
developed BCCs of the NAC and their
management.
METHODS
Using the PubMed database, a literature search
was performed searching for articles related to
BCC of the nipple or NAC published in the
world literature. The following keywords were
used: areola, basal cell carcinoma, and nipple.
Relevant papers were reviewed, and the
references cited in these papers were
evaluated. Information pertaining to age, sex,
site of BCC, morphology of BCC, histological
subtype of BCC, presence of pigment on
histology, previous history of BCC, risk factors,
treatment, lymph node involvement, and
clinical outcome was identified from each case
report. Additional informed consent was
obtained from one patient for whom
identifying information is included in this
article.
RESULTS
Fifty-five patients with BCC of the nipple and
areola have been reported in the world
literature, including the patient described in
Figs. 1 and 2 (Tables 1, 2) [2, 4–51]. BCC of this
site occurred more frequently in males (35,
63.6%) than in females (20, 36.4%). The onset
age ranged from 35 to 86 years old. The median
onset age in males was 61 years, whereas the
median onset age in females was 66 years. The
onset age was not mentioned for one female [6].
BCCs of the nipple-areola complex were
observed on the left (28/51, 54.9%) more
frequently than the right (23/51, 45.1%). One
patient had bilateral involvement of the areola
[37]. Five cases did not report the side affected.
The nipple was affected in 45 patients (81.8%);
22 of these individuals also had tumors that
affected the areola.
The majority of patients reported were
Caucasian (28/37, 75.7%). However, BCC of
the NAC was also described in 7 Asians (18.9%),
1 African American (2.7%), and 1 Hispanic
(2.7%) patient. Ethnicity or race was not
described in 18 cases.
Clinical presentation was variable and
presented as a plaque (17/34, 50%), nodule (8/
34, 23.5%), papule (6/34, 17.6%), macule (2/34,
5.9%), or patch (1/34, 2.9%). Secondary
changes were additionally noted: ulceration or
erosion of the BCC was noted in 19 cases, scale
in 10, and crust in 7. Clinically, eight BCCs were
pigmented.
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The most frequent BCC histologic type
reported was nodular (18/42, 42.9%). Other
histologic subtypes of BCC observed were
superficial (13/42, 30.9%), mixed (7/42,
16.7%), fibroepithelioma of pinkus (4/42,
9.5%), and pigmented (11/42, 26.2%). Of
mixed subtypes, four were noted to have
aggressive features on histology, including
infiltrative (3/7, 42.9%) and micronodular (1/
7, 14.3%). Thirteen cases did not provide a
histological subtype of BCC.
Removal of the tumor was the most common
treatment (Tables 1, 2, and 3). This included
either simple excision, being the most
frequently performed (15/50, 30%), wide
excision (14/50, 28%), or Mohs micrographic
surgery (11/50, 22%) with examination of the
margins during the excision to confirm
complete tumor removal. Six patients had
Fig. 1 a, b A previously unreported clinical presentation
of basal cell carcinoma of the areola. Distant view (a) of a
ﬂesh-colored to hypopigmented dermal nodule on the
upper medial quadrant of the right areola in a 67-year-old
Caucasian male with Fitzpatrick skin type 2. He had a
prior history of basal cell carcinoma on the left arm
diagnosed 3 years earlier and presented with a 6-month
history of a slowly enlarging, asymptomatic lesion on the
right areola and adjacent breast. He had a prior history of
moderate sun exposure as a young adult. He had no
exposure to ionizing radiation and had no family history of
basal cell carcinoma or basal cell nevus syndrome. Closer
view (b) of the right breast shows the 7 9 7-mm
ﬂesh-colored to hypopigmented dermal nodule on the
upper medial quadrant of his right areola and extending
into the adjacent breast. A 3-mm punch biopsy was
performed. The patient in these ﬁgures is also cited in
Table 1 (case 35)
Fig. 2 a, b A previously unreported pathologic presentation
of the basal cell carcinoma of the areola shown in Fig. 1.
Low (a) and higher (b) magniﬁcation views of the
pigmented basal cell carcinoma show nodular aggregates
of basaloid tumor cells extending from the epidermis into
the dermis (a). Deposits of melanin were present not only
in the tumor cells but also in dermal melanophages (b).
The residual tumor was excised using the Mohs micro-
graphic technique, and clear margins were achieved after
three stages. The ﬁnal wound measured 20 9 14 mm and a
layered side-to-side closure was used to close the surgical
defect. The patient in these ﬁgures is also cited in Table 1
(case 35)
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simple mastectomies as their initial modality of
treatment (6/50, 12%).
One patient received topical 5-flourouracil
(5-FU) twice daily for 6 weeks [50]. One female
was treated with etretinate followed by simple
mastectomy [35]. In addition, two patients
received no treatment [25, 36]. In five males,
there was no mention of management.
One male had Mohs micrographic surgery,
which showed the lactiferous ducts had been
infiltrated; thus, a simple mastectomy was
performed (2%) [32]. One male had a simple
excision followed by radiotherapy, but 4 years
later was noted to have recurrence in the
axillary lymph node and thus had a simple
mastectomy (2%) [2]. One female had a simple
excision, but due to positive margins, she
subsequently had a partial mastectomy (2%)
[43].
Most of the patients (43/45, 95.6%) had no
recurrence after successful treatment of their
tumor. In ten patients, there was no mention of
clinical outcome. There had been three reported
cases of metastatic disease to the lymph nodes
at the time of this review, and of these patients,
one died from the disease.
DISCUSSION
BCCs infrequently occur at unusual sites, such
as the nipple and areola. Previous studies have
Table 3 Initial treatment of basal cell carcinomas of the nipple-areola complex
Initial treatmenta Malesb Femalesnc Totald
Simple excision 10e 5f 15
Wide excision 6 8g 14
MMS 8h 3 11
Simple mastectomy 5 1i 6j
5-Fluorouracil 0 1k 1
Etretinate 0 1l 1
No treatment 1 1 2
Total 30 20 50
MMS Mohs micrographic surgery
a Initial treatment not stated in 5 males
b Number of males for whom treatment was performed
c Number of females for whom treatment was performed
d Total number of males and females for whom treatment was performed
e This group includes one patient whose nipple was excised, and the excision type was not speciﬁed. Two patients had
subsequent treatment including either axillary lymph node sampling or radiotherapy
f One female had additional treatment: simple mastectomy and lymph node sampling
g One female had additional treatment: radiotherapy
h Following MMS, one male had a simple mastectomy
i One female was treated with etretinate and subsequently had a simple mastectomy
j Simple mastectomy was the initial treatment for six patients; however, nine mastectomies were eventually performed. One
male was initially treated with MMS, and one female initially treated by simple excision followed by radiotherapy; one
female was initially treated with etretinate
k One female was treated with 5-ﬂuorouracil twice daily for 6 weeks. The BCC initially resolved, but recurred at 22 months
l Following etretinate therapy, one female had a simple mastectomy
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noted a close histogenic relationship between
BCCs and pilosebaceous units [52–54], and
BCCs are therefore thought to arise in
proportion to the number of pilosebaceous
units present [25]. The nipple and areola are
deficient in these units, which may explain the
paucity of BCCs of the nipple and areola.
After an extensive world literature search,
we identified 55 cases of BCC of the NAC from
1893 to 2016 (123 years). A 2009 review by
Ferguson et al. revealed 33 cases of BCC of the
nipple and areola [55]. Since 2009, 22
additional cases of BCC of the NAC have
been reported in the world literature. This
apparent increase in BCCs of this site may be
due to a publication bias; however, this trend
reflects an overall increased incidence of
sporadic BCCs [56].
The increased incidence of BCC of the NAC
observed in males (35, 63.6%) versus females (20,
36.4%) [2, 4–51] has been attributed to greater
sun exposure of the chest in males
[2, 13, 15, 20, 27, 41, 42]. Although ultraviolent
light exposure is the major risk factor for the
development of BCC, other etiologies include
arsenic exposure, genetic predisposition,
environmental exposures, immunosuppression,
ionizing radiation exposure, injury (burns or
trauma), light-colored skin, previous BCCs at
another site, and sunburns. Although the
majority of cases did not reveal possible risk
factors of BCC of the NAC, our review revealed
two males (Table 1, cases 11 and 26) [13, 27] and
two females (Table 2, cases 8 and 13) [40, 44] had
increased sun exposure to the chest from shirtless
sunbathing. Nine patients (9/26, 34.6%) had a
prior history of BCC [14, 17, 20, 21, 25, 28, 32].
Two males reported prior trauma to the chest (2/
27, 7.4%) [14, 21]. One male had basal cell nevus
syndrome (1/27, 3.7%) [28], and one male was
immunosuppressed on chemotherapy for gastric
cancer (1/27, 3.7%) [31].
To date, there have been eight patients with
clinically pigmented BCCs of the NAC.
Therefore, primary melanoma of the NAC,
pigmented Paget disease, and pigmented
epidermotropic metastases are important
considerations in the clinical differential
diagnosis of a pigmented lesion of the NAC.
These can be differentiated by histologic
examination and immunohistochemistry
markers, such as CEA, cytokeratins, EMA,
HMB-45, MART1, microphthalmia
transcription factor (MiTF), and S-100 [29, 57].
Interestingly, two patients (including the
patient described in Figs. 1 and 2) with
histologic findings of pigmented BCC had
flesh-colored non-pigmented clinical lesions
[50]. The clinical presentation of one male
with microscopic pigmented BCC was not
described [6].
Confirmation of BCC of the NAC requires a
biopsy, although other approaches are available
to evaluate a suspected diagnosis of BCC,
including confocal laser scanning microscopy
and dermoscopy.
Confocal laser scanning microscopy, also
known as reflective confocal microscopy, is a
noninvasive diagnostic method that enables
real-time imaging of the skin layers and
cellular structures in the horizontal plane [58].
Classical findings of BCC on confocal laser
scanning microscopy include five confocal
imaging criteria: presence of elongated
monomorphic basaloid nuclei, polarization of
these nuclei along the same axis of orientation,
heavy inflammatory infiltrate, increased
vasculature, and pleomorphism of the
overlying epidermis indicating actinic damage
[59].
Dermoscopy is another noninvasive method
that allows for the in vivo evaluation of
structures and colors of the epidermis,
dermoepidermal junction, and papillary
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dermis not visible to the unaided eye.
Dermoscopic diagnosis of BCC involves the
absence of a pigmented network and presence
of at least one of the following classical criteria:
multiple blue-gray globules, large blue-gray
ovoid nests, maple leaf-like areas, spoke-wheel
areas, arborizing telangiectasia, and ulceration
[60]. Non-classical dermoscopic criteria are also
helpful for the diagnosis of BCCs, especially
early lesions, and include short fine superficial
telangiectasia, concentric structures, multiple
small erosions, multiple in-focus blue-gray dots,
blue whitish veil, shiny pink-white areas, and
milia-like cysts [61].
Due to the infrequent presentation of BCC of
the NAC, there has been a lack of characteristic
findings in the literature to aid in the diagnosis
of BCC of the NAC. However, a recent review by
Kitamura et al. revealed a dermoscopic feature
of pigmented BCC of the NAC that was termed
a ‘large black web.’ On dermoscopic evaluation,
it was noted that the black network structure
was thicker than the typical pigment network of
the areola, and the surrounding area consisted
of arborizing vessels and spoke-wheel areas.
When this patient was compared with nine
others diagnosed with superficial BCC of the
trunk, the authors found that the ‘large black
web’ was unique to BCC of the NAC and
appeared to avoid the hair follicles [33].
Earlier investigations have reported an
increased metastatic potential of BCC of the
nipple and areola. These studies hypothesized
that the increased lymphatics of the NAC may
provide a direct route for tumor spread. There
have been three cases of BCC of the NAC with
lymph node involvement (Table 1, cases 2, 5,
and 12) [2, 5, 8], which is a minimum
metastatic rate of 5.5%. Since the outcome was
not stated in ten patients and several patients
had a short duration of follow-up after surgery,
this rate could potentially be higher.
The histologic subtypes observed were most
commonly nodular (42.9%) and superficial
(30.9%); less often they showed pigment
microscopically (11/42, 26.2%), mixed
histology (16.7%), or fibroepithioloma of
Pinkus variant (9.5%). Of the mixed subtypes,
four cases were noted to have features
associated with aggressive subtypes, such as
infiltrative (3/7, 42.9%) and micronodular (1/
7, 14.3%) BCCs.
Given the concern for higher metastatic
potential or the presence of positive excision
margins for tumors, nine patients underwent a
simple mastectomy, although tissue-sparing
surgery, such as simple excision, wide local
excision, and Mohs micrographic surgery, was
most commonly utilized. Recurrence of NAC
BCC is low and was noted in one male who
demonstrated lymph node involvement that
occurred 4 years after simple excision [2].
CONCLUSION
BCC of the NAC has been reported in 55
individuals. More males were affected than
females; the left side was affected more than
the right. Most commonly, these tumors
presented as plaques with ulceration. The most
frequent histologic subtype of BCC of NAC was
nodular BCC. Although previous reports raise
the concern of metastatic potential, most
patients have been successfully treated with
excision of the tumor.
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